Paul Strumph, MD

Chief medical officer at Seraxis Pharmaceuticals

Articles by Paul Strumph, MD

Bidirectionality of the Relaunched Myasthenia Gravis Patient Registry: Paul Strumph, MD

February 19th 2023

The lead of the Myasthenia Gravis Foundation of America Global Myasthenia Gravis Patient Registry spoke on 2 additional attributes of the patient registry. [WATCH TIME: 3 minutes]

Using the Myasthenia Gravis Patient Registry Management for Research Studies: Paul Strumph, MD

ByPaul Strumph, MD

February 9th 2023

The lead of the Myasthenia Gravis Foundation of America’s Global Myasthenia Gravis Patient Registry spoke about the registry from a research project perspective. [WATCH TIME: 4 minutes]

Paul Strumph, MD

Articles by Paul Strumph, MD

Bidirectionality of the Relaunched Myasthenia Gravis Patient Registry: Paul Strumph, MD

Using the Myasthenia Gravis Patient Registry Management for Research Studies: Paul Strumph, MD

Latest Updated Articles

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential

Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc

Ketogenic Diet Shows Significant Effect on Seizure Reduction in Children With Drug-Resistant Epilepsy

De-Escalation Strategies in Multiple Sclerosis: Oral Therapies and Cladribine

COAST Trial: Evaluating Ozanimod Step-Down in Multiple Sclerosis